tetano
Editor, Senior Moderator
Indian Pediatr
. 2022 Aug 15;59(8):617-619.
Outcome of COVID-19 in Children With Tuberculosis: Single-Center Experience
Sushant S Mane[SUP] 1 [/SUP], Jyothi Janardhanan[SUP] 1 [/SUP], Manas Pustake[SUP] 2 [/SUP], Akshay Wanvat[SUP] 1 [/SUP], Gazi Israil Khan[SUP] 1 [/SUP], Rajratna Chopade[SUP] 1 [/SUP]
Affiliations
Abstract
Objective: To evaluate the outcome of Coronavirus disease 2019 (COVID-19) infection in children and adolescents with tuberculosis.
Methods: We analyzed hospital records for the period May, 2020 to September, 2021 for children who were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcriptase-polymerase chain reaction (RT-PCR) positive or SARS-CoV-2 antibody positive. They were divided into two groups viz., those with tuberculosis (tuberculosis group) and those without tuberculosis (non-TB group). Demographic information, symptoms, and outcomes of COVID-19 were compared between the two groups.
Results: Median (IQR) age of participants was 11 (8,14) and 4.5 (2,9) year for the tuberculosis and non-TB groups, respectively. 93.5% and 36.1% of children were asymptomatic in the tuberculosis and non-TB group, respectively. No variable in the study was significantly associated with COVID-19 positivity in children with tuberculosis. No difference was found in the outcomes of COVID-19 infection in children having tuberculosis.
Conclusions: No differences were noted in the outcomes of COVID-19 infection in children having tuberculosis.
. 2022 Aug 15;59(8):617-619.
Outcome of COVID-19 in Children With Tuberculosis: Single-Center Experience
Sushant S Mane[SUP] 1 [/SUP], Jyothi Janardhanan[SUP] 1 [/SUP], Manas Pustake[SUP] 2 [/SUP], Akshay Wanvat[SUP] 1 [/SUP], Gazi Israil Khan[SUP] 1 [/SUP], Rajratna Chopade[SUP] 1 [/SUP]
Affiliations
- PMID: 35962655
Abstract
Objective: To evaluate the outcome of Coronavirus disease 2019 (COVID-19) infection in children and adolescents with tuberculosis.
Methods: We analyzed hospital records for the period May, 2020 to September, 2021 for children who were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcriptase-polymerase chain reaction (RT-PCR) positive or SARS-CoV-2 antibody positive. They were divided into two groups viz., those with tuberculosis (tuberculosis group) and those without tuberculosis (non-TB group). Demographic information, symptoms, and outcomes of COVID-19 were compared between the two groups.
Results: Median (IQR) age of participants was 11 (8,14) and 4.5 (2,9) year for the tuberculosis and non-TB groups, respectively. 93.5% and 36.1% of children were asymptomatic in the tuberculosis and non-TB group, respectively. No variable in the study was significantly associated with COVID-19 positivity in children with tuberculosis. No difference was found in the outcomes of COVID-19 infection in children having tuberculosis.
Conclusions: No differences were noted in the outcomes of COVID-19 infection in children having tuberculosis.